IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,239 | -44.7% | 34,461 | -9.0% | 0.04% | -43.5% |
| Q2 2023 | $105,329 | +285.6% | 37,888 | +152.4% | 0.06% | +313.3% |
| Q1 2023 | $27,316 | -74.1% | 15,009 | -27.8% | 0.02% | -72.7% |
| Q4 2022 | $105,365 | -39.4% | 20,782 | -40.7% | 0.06% | -20.3% |
| Q3 2022 | $174,000 | +34.9% | 35,048 | +0.7% | 0.07% | +43.8% |
| Q2 2022 | $129,000 | -15.7% | 34,799 | +27.3% | 0.05% | -29.4% |
| Q1 2022 | $153,000 | -13.1% | 27,343 | -5.6% | 0.07% | +3.0% |
| Q4 2021 | $176,000 | +26.6% | 28,969 | +103.4% | 0.07% | +8.2% |
| Q3 2021 | $139,000 | -35.0% | 14,244 | -4.9% | 0.06% | -30.7% |
| Q2 2021 | $214,000 | -65.1% | 14,982 | -42.0% | 0.09% | -66.0% |
| Q1 2021 | $614,000 | – | 25,850 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |